The Future of Gender-Affirming Care — A Law and Policy Perspective on the Cass Review

Claim:

Published on 15 January, the new report, which analysed the Cass from a law and policy perspective, claimed that it “departed from standard practice… [and] deviates from pharmaceutical regulatory standards” while making recommendations that are “not applied elsewhere in paediatric medicine”.